Top Health Care Stocks
Health care stocks slumped this afternoon, with the NYSE Health Care Index dropping 0.6% while shares of health care companies in the S&P 500 also were up nearly 0.6% as a group.
In company news, TG Therapeutics ( TGTX ) was higher shortly before Tuesday's closing bell after today confirming the U.S. Food and Drug Administration has designated the company's combination of its TG-1101 and TG-1102 product candidates as an orphan drug for the treatment for diffuse large b-cell lymphoma.
The drug combination currently is being evaluated in Phase IIb Trial for patients with relapsed or refractory large B-cell lyphoma as well as in Phase III testing in patients with both frontline and previously treated chronic lymphocytic leukemia.
TGTX shares ended 10% higher at $4.68 each.
In other sector news,
(+) RMD, Q2 EPS of $0.73 exceeds consensus by $0.03 per share. Revenue climbs 16.7% to $530.4 mln, also beating the $516.28 mln consensus. JP Morgan raises investment rating to Overweight from Neutral. Canaccord Genuity increases price target by $4 to $59 a share.
(-) BIOA, Prices upsized $17.5 mln public offering of 3.68 mln shares of its common stock - a 75% increase over it original proposal - at $4.75 a share, a 9.7% discount to Monday's closing price. Issues four-year warrants to buy up to 1.84 mln more shares at $5.50 each
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.